Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS
· Delayed Price · Currency is USD
0.500
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
Pharma-Bio Serv Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.76 | 3.38 | 6.77 | 10.45 | 14.46 | 17.47 | Upgrade
|
| Short-Term Investments | 4.8 | 7.48 | 5.98 | 4.53 | - | - | Upgrade
|
| Cash & Short-Term Investments | 10.56 | 10.85 | 12.75 | 14.98 | 14.46 | 17.47 | Upgrade
|
| Cash Growth | -15.07% | -14.84% | -14.90% | 3.56% | -17.21% | 1.93% | Upgrade
|
| Accounts Receivable | 2.65 | 2.36 | 2.51 | 3.94 | 4.98 | 4.61 | Upgrade
|
| Receivables | 2.65 | 2.36 | 2.51 | 3.94 | 4.98 | 4.61 | Upgrade
|
| Prepaid Expenses | 0.11 | 0.17 | 0.44 | 0.48 | 0.5 | 0.74 | Upgrade
|
| Total Current Assets | 13.32 | 13.39 | 15.7 | 19.4 | 19.94 | 22.82 | Upgrade
|
| Property, Plant & Equipment | 0.1 | 0.15 | 0.37 | 0.39 | 0.58 | 0.75 | Upgrade
|
| Other Long-Term Assets | 0.12 | 0.12 | 0.23 | 0.11 | 0.13 | 0.35 | Upgrade
|
| Total Assets | 13.55 | 13.65 | 16.29 | 19.9 | 20.65 | 23.92 | Upgrade
|
| Accounts Payable | 0.87 | 0.99 | 1.13 | 1.47 | 1.63 | 2.09 | Upgrade
|
| Current Portion of Leases | - | 0.03 | 0.17 | 0.15 | 0.14 | 0.13 | Upgrade
|
| Current Income Taxes Payable | 0.72 | 0.72 | 0.59 | 0.53 | 0.34 | 0.45 | Upgrade
|
| Other Current Liabilities | 1.72 | - | - | - | - | - | Upgrade
|
| Total Current Liabilities | 3.31 | 1.74 | 1.89 | 2.15 | 2.11 | 2.67 | Upgrade
|
| Long-Term Leases | - | - | 0.03 | 0.19 | 0.35 | 0.49 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.66 | 1.43 | 1.64 | 1.85 | Upgrade
|
| Total Liabilities | 3.31 | 1.74 | 2.58 | 3.78 | 4.09 | 5.01 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1.69 | 1.68 | 1.64 | 1.6 | 1.55 | 1.48 | Upgrade
|
| Retained Earnings | 8.85 | 10.53 | 12.35 | 14.85 | 15.27 | 17.71 | Upgrade
|
| Treasury Stock | -0.58 | -0.58 | -0.55 | -0.54 | -0.5 | -0.42 | Upgrade
|
| Comprehensive Income & Other | 0.28 | 0.28 | 0.26 | 0.21 | 0.24 | 0.14 | Upgrade
|
| Shareholders' Equity | 10.24 | 11.91 | 13.72 | 16.13 | 16.56 | 18.91 | Upgrade
|
| Total Liabilities & Equity | 13.55 | 13.65 | 16.29 | 19.9 | 20.65 | 23.92 | Upgrade
|
| Total Debt | - | 0.03 | 0.19 | 0.35 | 0.49 | 0.62 | Upgrade
|
| Net Cash (Debt) | 10.56 | 10.83 | 12.55 | 14.63 | 13.98 | 16.85 | Upgrade
|
| Net Cash Growth | -14.01% | -13.75% | -14.21% | 4.69% | -17.07% | 16.91% | Upgrade
|
| Net Cash Per Share | 0.46 | 0.47 | 0.55 | 0.64 | 0.61 | 0.73 | Upgrade
|
| Filing Date Shares Outstanding | 22.9 | 22.9 | 22.96 | 22.96 | 22.95 | 22.97 | Upgrade
|
| Total Common Shares Outstanding | 22.9 | 22.91 | 22.96 | 22.96 | 22.94 | 23 | Upgrade
|
| Working Capital | 10.01 | 11.65 | 13.81 | 17.25 | 17.84 | 20.15 | Upgrade
|
| Book Value Per Share | 0.45 | 0.52 | 0.60 | 0.70 | 0.72 | 0.82 | Upgrade
|
| Tangible Book Value | 10.24 | 11.91 | 13.72 | 16.13 | 16.56 | 18.91 | Upgrade
|
| Tangible Book Value Per Share | 0.45 | 0.52 | 0.60 | 0.70 | 0.72 | 0.82 | Upgrade
|
| Machinery | - | 0.31 | 0.68 | 0.67 | 0.66 | 0.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.